Does informant‐based reporting of cognitive symptoms predict amyloid positivity on positron emission tomography?
Abstract Introduction Researchers are searching for clinical instruments to predict amyloid positivity for disease classification. Informant‐based reports could detect disease status. This study compares subjective memory complaints captured by informant‐based reports between positron emission tomog...
Main Authors: | Hannah E. Brunet, Justin B. Miller, Jiong Shi, Briana Chung, Bryce Taylor Munter, Marwan Noel Sabbagh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-12-01
|
Series: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
Subjects: | |
Online Access: | https://doi.org/10.1016/j.dadm.2019.04.004 |
Similar Items
-
Matching Clinical Diagnosis and Amyloid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia
by: Giulia Giacomucci, et al.
Published: (2021-01-01) -
Integrated 18F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging (18F-FDG PET/MRI), a multimodality approach for comprehensive evaluation of dementia patients: A pictorial essay
by: Amarnath Jena, et al.
Published: (2015-10-01) -
Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer’s disease dementia from normal controls: preliminary findings
by: Marwan N Sabbagh, et al.
Published: (2018-09-01) -
Amyloid positron emission tomography candidates may focus more on benefits than risks of results disclosure
by: Jennifer H. Lingler, et al.
Published: (2018-01-01) -
Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET
by: Chetsadaporn Promteangtrong, et al.